AGP Executive Report
Last update: 7 hours agoTreatment Research: A review found little support for medical cannabis as an insomnia treatment. Other studies reported links between prenatal cannabis-and-tobacco exposure and lower childhood thinking-test scores, and between occasional cannabis use and stroke risk; these findings do not prove cause. U.S. Policy: Massachusetts voters rejected a bid to repeal legal cannabis sales, while Wisconsin Democrats’ new legislative majority has raised hopes for legalization. Federal rescheduling proceedings face a Nov. 5 filing deadline amid calls for stronger safety oversight. Medical Access: The DEA has begun registering more than 900 state-licensed medical dispensaries, a move that could ease research and tax barriers. New state rules may also increase demand for specialized healthcare training. Hemp and CBD: A coming federal ban on many hemp-derived products and uncertainty over banking for emerging legal markets underscore the sector’s regulatory hurdles.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.